BME company profiles entelos: predictive model systems for disease

Stokes: Entelos is a biopharmaceutical company and the commercial leader in predictive biosimulation. We carry out pharmaceutical research and development using our proprietary PhysioLab biosimulation technology to significantly reduce the time, cost, and risk required to discover and develop new drugs. Much of our work is in collaboration with other pharmaceutical and biotechnology companies in the areas of metabolic and inflammatory diseases. Founded in 1996 with the mission to apply simulation and decision-support technologies to problems facing pharmaceutical research and development (R&D), we’ve evolved into the foremost experts in creating and using predictive model systems of health and disease in drug discovery and development. We employ life scientists with expertise spanning molecular biology and clinical medicine in fields related to metabolism, inflammation, and immunology and engineers with backgrounds in dynamics and control, including chemical, electrical, mechanical, and aeronautical engineering. Currently, the company has about 75 employees.